Ozempic (semaglutide) is a medication primarily used to manage type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists, which help lower blood sugar levels and promote weight loss.
No, Ozempic is not officially approved for treating prediabetes. It is specifically approved for managing type 2 diabetes. However, some healthcare providers may prescribe it off-label for prediabetes, especially if you are at high risk of developing diabetes or have other conditions like obesity.
While not approved for prediabetes, Ozempic may help by:
Using Ozempic for prediabetes may come with risks, including:
While Ozempic is not approved for prediabetes, it may be an option for some individuals at high risk of developing diabetes. Always consult your healthcare provider to determine the best course of action for managing your prediabetes.